{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:18:25Z","timestamp":1791001105057,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radonc.2023.110023","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:55:47Z","timestamp":1700643347000},"page":"110023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation"],"prefix":"10.1016","volume":"190","author":[{"given":"Geng-Min","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Miao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-6895","authenticated-orcid":false,"given":"Ze-Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Zhou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Chun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ming","family":"Spring Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.110023_b0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1200\/JCO.21.01611","article-title":"Inoperable Early-Stage Non-Small-Cell Lung Cancer: Stereotactic Ablative Radiotherapy and Rationale for Systemic Therapy","volume":"40","author":"Daly","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.semcancer.2020.06.018","article-title":"Stereotactic ablative radiotherapy for colorectal cancer liver metastasis","volume":"71","author":"Wang","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.radonc.2023.110023_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.21.01719","article-title":"Practical Management of Oligometastatic Non-Small-Cell Lung Cancer","volume":"40","author":"Jasper","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2022.06.017","article-title":"The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma","volume":"82","author":"Ali","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2023.110023_b0025","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2017.01.244","article-title":"Tolerance of the Brachial Plexus to High-Dose Reirradiation","volume":"98","author":"Chen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13014-021-01822-5","article-title":"Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experience","volume":"16","author":"Kapitanova","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canrad.2022.06.010","article-title":"Radiation induced brachial plexopathy: Diagnosis, risk factors, principles of care","volume":"27","author":"Miran","year":"2023","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2023.110023_b0055","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtho.2019.08.2505","article-title":"Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC","volume":"15","author":"Moreno","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2021.04.014","article-title":"Stereotactic Body Radiation Therapy With a High Maximum Dose Improves Local Control, Cancer-Specific Death, and Overall Survival in Peripheral Early-Stage Non-Small Cell Lung Cancer","volume":"111","author":"Tateishi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijrobp.2014.10.002","article-title":"Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer","volume":"91","author":"Koshy","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.radonc.2009.04.018","article-title":"Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites","volume":"93","author":"Forquer","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0080","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ijrobp.2014.01.022","article-title":"Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a \u201cno fly zone\u201d","volume":"88","author":"Chang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0085","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/0284186X.2019.1601255","article-title":"Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions","volume":"58","author":"Lindberg","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0090","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.prro.2021.12.002","article-title":"Stereotactic Body Radiation Therapy for Apical Lung Tumors: Dosimetric Analysis of the Brachial Plexus and Preliminary Clinical Outcomes","volume":"12","author":"Morse","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.adro.2017.10.002","article-title":"Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes","volume":"3","author":"Sood","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0100","first-page":"189","article-title":"Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapy","volume":"6","author":"Manyam","year":"2019","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.radonc.2023.110023_b0105","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/j.prro.2022.12.002","article-title":"Brachial Plexopathy After Single-Fraction Stereotactic Body Radiation Therapy in Apical Lung Tumors","volume":"13","author":"Iovoli","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0110","article-title":"Hypofractionated Stereotactic Radiation Therapy Dosimetric Tolerances for the Inferior Aspect of the Brachial Plexus: A Systematic Review","author":"Milano","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0115","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0120","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0125","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2018.1251","article-title":"Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2013.11.244","article-title":"Dose\u2013volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol","volume":"88","author":"Chen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijrobp.2011.11.019","article-title":"Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer","volume":"84","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.coc.0000107891.65644.46","article-title":"A patient questionnaire for radiation-induced brachial plexopathy","volume":"27","author":"Hoeller","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0150","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/cas.14185","article-title":"Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer","volume":"110","author":"Meng","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2023.110023_b0155","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/cas.15559","article-title":"Risk-adapted stereotactic body radiotherapy for patients with cervical spinal metastases","volume":"113","author":"Wang","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2023.110023_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109804","article-title":"Impact of radiation dose to the immune system on disease progression and survival for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"186","author":"Wang","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A Story of Hypofractionation and the Table on the Wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0170","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109583","article-title":"Radiation-induced inferior brachial plexopathy after stereotactic body radiotherapy: Pooled analyses of risks","volume":"182","author":"Milano","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0185","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2014.10.015","article-title":"SBRT in pancreatic cancer: what is the therapeutic window?","volume":"114","author":"Brunner","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0195","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ijrobp.2018.02.035","article-title":"Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity","volume":"101","author":"Ling","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0200","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ijrobp.2021.12.008","article-title":"Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus","volume":"112","author":"Sodji","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13014-014-0292-5","article-title":"Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy","volume":"9","author":"Wu","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2011.12.017","article-title":"Long-term symptoms after radiotherapy of supraclavicular lymph nodes in breast cancer patients","volume":"103","author":"Lundstedt","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110023_b0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2015.01.016","article-title":"Radiation Therapy to the Plexus Brachialis in Breast Cancer Patients: Analysis of Paresthesia in Relation to Dose and Volume","volume":"92","author":"Lundstedt","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0220","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.ijrobp.2011.06.1961","article-title":"Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer","volume":"82","author":"Amini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110023_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2020.10.039","article-title":"High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview","volume":"110","author":"Grimm","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T09:09:25Z","timestamp":1734253765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023093301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":45,"alternative-id":["S0167814023093301"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110023","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110023"}}